Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) DTaP and Tdap Vaccines Market 2018, Forecast to 2023
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free environment. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. In 2015, procurement of DTwP vaccine through UNICEF had reached 5.8 million doses for 18 countries and territories out of which four countries such as Egypt, Morocco, Uzbekistan, and Zimbabwe accounted for more than 80% of UNICEF?s total procurement.
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%?85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
SCOPE OF THE REPORT:
This report focuses on the DTaP and Tdap Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for DTaP and Tdap Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe DTaP and Tdap Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of DTaP and Tdap Vaccines, with sales, revenue, and price of DTaP and Tdap Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of DTaP and Tdap Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, DTaP and Tdap Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe DTaP and Tdap Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.
The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%?85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.
SCOPE OF THE REPORT:
This report focuses on the DTaP and Tdap Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for DTaP and Tdap Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Sanofi Pasteur
- GlaxoSmithKline
- Protein Sciences Corporation
- Novartis AG
- Seqirus
- Merck Sharp & Dohme Corp
- Astellas Pharma US, Inc
- Pfizer Inc
- Johnson & Johnson
- Lanzhou Institute of Biological Products Co., Ltd
- AstraZeneca
- Emergent BioSolutions Inc
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- DTaP
- Td
- Tdap
- Adult
- Pediatric
Chapter 1, to describe DTaP and Tdap Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of DTaP and Tdap Vaccines, with sales, revenue, and price of DTaP and Tdap Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of DTaP and Tdap Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, DTaP and Tdap Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe DTaP and Tdap Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 DTaP and Tdap Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 DTaP
1.2.2 Td
1.2.3 Tdap
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Pediatric
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Sanofi Pasteur
2.1.1 Business Overview
2.1.1.1 Sanofi Pasteur Description
2.1.1.2 Sanofi Pasteur Headquarter, Main Business and Finance Overview
2.1.2 Sanofi Pasteur DTaP and Tdap Vaccines Product Introduction
2.1.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.1.2.2 DTaP and Tdap Vaccines Product Information
2.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Sanofi Pasteur DTaP and Tdap Vaccines Market Share in 2017
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.1.1 GlaxoSmithKline Description
2.2.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.2.2 GlaxoSmithKline DTaP and Tdap Vaccines Product Introduction
2.2.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.2.2.2 DTaP and Tdap Vaccines Product Information
2.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global GlaxoSmithKline DTaP and Tdap Vaccines Market Share in 2017
2.3 Protein Sciences Corporation
2.3.1 Business Overview
2.3.1.1 Protein Sciences Corporation Description
2.3.1.2 Protein Sciences Corporation Headquarter, Main Business and Finance Overview
2.3.2 Protein Sciences Corporation DTaP and Tdap Vaccines Product Introduction
2.3.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.3.2.2 DTaP and Tdap Vaccines Product Information
2.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Protein Sciences Corporation DTaP and Tdap Vaccines Market Share in 2017
2.4 Novartis AG
2.4.1 Business Overview
2.4.1.1 Novartis AG Description
2.4.1.2 Novartis AG Headquarter, Main Business and Finance Overview
2.4.2 Novartis AG DTaP and Tdap Vaccines Product Introduction
2.4.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.4.2.2 DTaP and Tdap Vaccines Product Information
2.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Novartis AG DTaP and Tdap Vaccines Market Share in 2017
2.5 Seqirus
2.5.1 Business Overview
2.5.1.1 Seqirus Description
2.5.1.2 Seqirus Headquarter, Main Business and Finance Overview
2.5.2 Seqirus DTaP and Tdap Vaccines Product Introduction
2.5.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.5.2.2 DTaP and Tdap Vaccines Product Information
2.5.3 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Seqirus DTaP and Tdap Vaccines Market Share in 2017
2.6 Merck Sharp & Dohme Corp
2.6.1 Business Overview
2.6.1.1 Merck Sharp & Dohme Corp Description
2.6.1.2 Merck Sharp & Dohme Corp Headquarter, Main Business and Finance Overview
2.6.2 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Introduction
2.6.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.6.2.2 DTaP and Tdap Vaccines Product Information
2.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Market Share in 2017
2.7 Astellas Pharma US, Inc
2.7.1 Business Overview
2.7.1.1 Astellas Pharma US, Inc Description
2.7.1.2 Astellas Pharma US, Inc Headquarter, Main Business and Finance Overview
2.7.2 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Introduction
2.7.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.7.2.2 DTaP and Tdap Vaccines Product Information
2.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Astellas Pharma US, Inc DTaP and Tdap Vaccines Market Share in 2017
2.8 Pfizer Inc
2.8.1 Business Overview
2.8.1.1 Pfizer Inc Description
2.8.1.2 Pfizer Inc Headquarter, Main Business and Finance Overview
2.8.2 Pfizer Inc DTaP and Tdap Vaccines Product Introduction
2.8.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.8.2.2 DTaP and Tdap Vaccines Product Information
2.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Pfizer Inc DTaP and Tdap Vaccines Market Share in 2017
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.1.1 Johnson & Johnson Description
2.9.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.9.2 Johnson & Johnson DTaP and Tdap Vaccines Product Introduction
2.9.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.9.2.2 DTaP and Tdap Vaccines Product Information
2.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Johnson & Johnson DTaP and Tdap Vaccines Market Share in 2017
2.10 Lanzhou Institute of Biological Products Co., Ltd
2.10.1 Business Overview
2.10.1.1 Lanzhou Institute of Biological Products Co., Ltd Description
2.10.1.2 Lanzhou Institute of Biological Products Co., Ltd Headquarter, Main Business and Finance Overview
2.10.2 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Introduction
2.10.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.10.2.2 DTaP and Tdap Vaccines Product Information
2.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Market Share in 2017
2.11 AstraZeneca
2.11.1 Business Overview
2.11.2 AstraZeneca DTaP and Tdap Vaccines Product Introduction
2.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Emergent BioSolutions Inc
2.12.1 Business Overview
2.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Introduction
2.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL DTAP AND TDAP VACCINES MARKET COMPETITION, BY MANUFACTURER
3.1 Global DTaP and Tdap Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global DTaP and Tdap Vaccines Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 DTaP and Tdap Vaccines Manufacturer Market Share in 2017
3.4.2 Top 5 DTaP and Tdap Vaccines Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DTAP AND TDAP VACCINES MARKET ANALYSIS BY REGIONS
4.1 Global DTaP and Tdap Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global DTaP and Tdap Vaccines Sales by Regions (2013-2018)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Regions (2013-2018)
4.2 North America DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.5 South America DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
5.1.2 North America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
5.1.3 United States DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
5.1.4 Canada DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
5.1.5 Mexico DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
5.2 North America DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
5.2.2 North America DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
5.3 North America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
5.3.2 North America DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
5.4 North America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
5.4.2 North America DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe DTaP and Tdap Vaccines Sales by Countries (2013-2018)
6.1.2 Europe DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
6.1.3 Germany DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.4 UK DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.5 France DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.6 Russia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.7 Italy DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.2 Europe DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
6.2.2 Europe DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
6.3 Europe DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
6.3.2 Europe DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
6.4 Europe DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
6.4.2 Europe DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Countries (2013-2018)
7.1.2 Asia-Pacific DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
7.1.3 China DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.4 Japan DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.5 Korea DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.6 India DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
8.1.2 South America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
8.1.3 Brazil DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
8.1.4 Argentina DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
8.1.5 Colombia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
8.2 South America DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
8.2.2 South America DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
8.3 South America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
8.3.2 South America DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
8.4 South America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
8.4.2 South America DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Countries (2013-2018)
9.1.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.4 UAE DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.5 Egypt DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.6 Nigeria DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.7 South Africa DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DTAP AND TDAP VACCINES MARKET SEGMENT BY TYPE
10.1 Global DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global DTaP and Tdap Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2013-2018)
10.2 DTaP Sales Growth and Price
10.2.1 Global DTaP Sales Growth (2013-2018)
10.2.2 Global DTaP Price (2013-2018)
10.3 Td Sales Growth and Price
10.3.1 Global Td Sales Growth (2013-2018)
10.3.2 Global Td Price (2013-2018)
10.4 Tdap Sales Growth and Price
10.4.1 Global Tdap Sales Growth (2013-2018)
10.4.2 Global Tdap Price (2013-2018)
11 GLOBAL DTAP AND TDAP VACCINES MARKET SEGMENT BY APPLICATION
11.1 Global DTaP and Tdap Vaccines Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Pediatric Sales Growth (2013-2018)
12 DTAP AND TDAP VACCINES MARKET FORECAST (2018-2023)
12.1 Global DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 DTaP and Tdap Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.2 Europe DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.4 South America DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.3 DTaP and Tdap Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global DTaP and Tdap Vaccines Market Share Forecast by Type (2018-2023)
12.4 DTaP and Tdap Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global DTaP and Tdap Vaccines Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 DTaP and Tdap Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 DTaP
1.2.2 Td
1.2.3 Tdap
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Pediatric
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Sanofi Pasteur
2.1.1 Business Overview
2.1.1.1 Sanofi Pasteur Description
2.1.1.2 Sanofi Pasteur Headquarter, Main Business and Finance Overview
2.1.2 Sanofi Pasteur DTaP and Tdap Vaccines Product Introduction
2.1.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.1.2.2 DTaP and Tdap Vaccines Product Information
2.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Sanofi Pasteur DTaP and Tdap Vaccines Market Share in 2017
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.1.1 GlaxoSmithKline Description
2.2.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.2.2 GlaxoSmithKline DTaP and Tdap Vaccines Product Introduction
2.2.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.2.2.2 DTaP and Tdap Vaccines Product Information
2.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global GlaxoSmithKline DTaP and Tdap Vaccines Market Share in 2017
2.3 Protein Sciences Corporation
2.3.1 Business Overview
2.3.1.1 Protein Sciences Corporation Description
2.3.1.2 Protein Sciences Corporation Headquarter, Main Business and Finance Overview
2.3.2 Protein Sciences Corporation DTaP and Tdap Vaccines Product Introduction
2.3.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.3.2.2 DTaP and Tdap Vaccines Product Information
2.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Protein Sciences Corporation DTaP and Tdap Vaccines Market Share in 2017
2.4 Novartis AG
2.4.1 Business Overview
2.4.1.1 Novartis AG Description
2.4.1.2 Novartis AG Headquarter, Main Business and Finance Overview
2.4.2 Novartis AG DTaP and Tdap Vaccines Product Introduction
2.4.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.4.2.2 DTaP and Tdap Vaccines Product Information
2.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Novartis AG DTaP and Tdap Vaccines Market Share in 2017
2.5 Seqirus
2.5.1 Business Overview
2.5.1.1 Seqirus Description
2.5.1.2 Seqirus Headquarter, Main Business and Finance Overview
2.5.2 Seqirus DTaP and Tdap Vaccines Product Introduction
2.5.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.5.2.2 DTaP and Tdap Vaccines Product Information
2.5.3 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Seqirus DTaP and Tdap Vaccines Market Share in 2017
2.6 Merck Sharp & Dohme Corp
2.6.1 Business Overview
2.6.1.1 Merck Sharp & Dohme Corp Description
2.6.1.2 Merck Sharp & Dohme Corp Headquarter, Main Business and Finance Overview
2.6.2 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Introduction
2.6.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.6.2.2 DTaP and Tdap Vaccines Product Information
2.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Market Share in 2017
2.7 Astellas Pharma US, Inc
2.7.1 Business Overview
2.7.1.1 Astellas Pharma US, Inc Description
2.7.1.2 Astellas Pharma US, Inc Headquarter, Main Business and Finance Overview
2.7.2 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Introduction
2.7.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.7.2.2 DTaP and Tdap Vaccines Product Information
2.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Astellas Pharma US, Inc DTaP and Tdap Vaccines Market Share in 2017
2.8 Pfizer Inc
2.8.1 Business Overview
2.8.1.1 Pfizer Inc Description
2.8.1.2 Pfizer Inc Headquarter, Main Business and Finance Overview
2.8.2 Pfizer Inc DTaP and Tdap Vaccines Product Introduction
2.8.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.8.2.2 DTaP and Tdap Vaccines Product Information
2.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Pfizer Inc DTaP and Tdap Vaccines Market Share in 2017
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.1.1 Johnson & Johnson Description
2.9.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.9.2 Johnson & Johnson DTaP and Tdap Vaccines Product Introduction
2.9.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.9.2.2 DTaP and Tdap Vaccines Product Information
2.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Johnson & Johnson DTaP and Tdap Vaccines Market Share in 2017
2.10 Lanzhou Institute of Biological Products Co., Ltd
2.10.1 Business Overview
2.10.1.1 Lanzhou Institute of Biological Products Co., Ltd Description
2.10.1.2 Lanzhou Institute of Biological Products Co., Ltd Headquarter, Main Business and Finance Overview
2.10.2 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Introduction
2.10.2.1 DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
2.10.2.2 DTaP and Tdap Vaccines Product Information
2.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Market Share in 2017
2.11 AstraZeneca
2.11.1 Business Overview
2.11.2 AstraZeneca DTaP and Tdap Vaccines Product Introduction
2.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Emergent BioSolutions Inc
2.12.1 Business Overview
2.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Introduction
2.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL DTAP AND TDAP VACCINES MARKET COMPETITION, BY MANUFACTURER
3.1 Global DTaP and Tdap Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global DTaP and Tdap Vaccines Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 DTaP and Tdap Vaccines Manufacturer Market Share in 2017
3.4.2 Top 5 DTaP and Tdap Vaccines Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DTAP AND TDAP VACCINES MARKET ANALYSIS BY REGIONS
4.1 Global DTaP and Tdap Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global DTaP and Tdap Vaccines Sales by Regions (2013-2018)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Regions (2013-2018)
4.2 North America DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.5 South America DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
5.1.2 North America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
5.1.3 United States DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
5.1.4 Canada DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
5.1.5 Mexico DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
5.2 North America DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
5.2.2 North America DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
5.3 North America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
5.3.2 North America DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
5.4 North America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
5.4.2 North America DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe DTaP and Tdap Vaccines Sales by Countries (2013-2018)
6.1.2 Europe DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
6.1.3 Germany DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.4 UK DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.5 France DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.6 Russia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.1.7 Italy DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
6.2 Europe DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
6.2.2 Europe DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
6.3 Europe DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
6.3.2 Europe DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
6.4 Europe DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
6.4.2 Europe DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Countries (2013-2018)
7.1.2 Asia-Pacific DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
7.1.3 China DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.4 Japan DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.5 Korea DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.6 India DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
8.1.2 South America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
8.1.3 Brazil DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
8.1.4 Argentina DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
8.1.5 Colombia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
8.2 South America DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
8.2.2 South America DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
8.3 South America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
8.3.2 South America DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
8.4 South America DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
8.4.2 South America DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DTAP AND TDAP VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Countries (2013-2018)
9.1.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.4 UAE DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.5 Egypt DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.6 Nigeria DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.1.7 South Africa DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa DTaP and Tdap Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa DTaP and Tdap Vaccines Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa DTaP and Tdap Vaccines Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa DTaP and Tdap Vaccines Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa DTaP and Tdap Vaccines Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa DTaP and Tdap Vaccines Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DTAP AND TDAP VACCINES MARKET SEGMENT BY TYPE
10.1 Global DTaP and Tdap Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global DTaP and Tdap Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Type (2013-2018)
10.2 DTaP Sales Growth and Price
10.2.1 Global DTaP Sales Growth (2013-2018)
10.2.2 Global DTaP Price (2013-2018)
10.3 Td Sales Growth and Price
10.3.1 Global Td Sales Growth (2013-2018)
10.3.2 Global Td Price (2013-2018)
10.4 Tdap Sales Growth and Price
10.4.1 Global Tdap Sales Growth (2013-2018)
10.4.2 Global Tdap Price (2013-2018)
11 GLOBAL DTAP AND TDAP VACCINES MARKET SEGMENT BY APPLICATION
11.1 Global DTaP and Tdap Vaccines Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Pediatric Sales Growth (2013-2018)
12 DTAP AND TDAP VACCINES MARKET FORECAST (2018-2023)
12.1 Global DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 DTaP and Tdap Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.2 Europe DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.4 South America DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa DTaP and Tdap Vaccines Market Forecast (2018-2023)
12.3 DTaP and Tdap Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global DTaP and Tdap Vaccines Market Share Forecast by Type (2018-2023)
12.4 DTaP and Tdap Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global DTaP and Tdap Vaccines Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure DTaP and Tdap Vaccines Picture
Table Product Specifications of DTaP and Tdap Vaccines
Figure Global DTaP and Tdap Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global DTaP and Tdap Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of DTaP and Tdap Vaccines by Types in 2017
Figure DTaP Picture
Table Major Manufacturers of DTaP
Figure Td Picture
Table Major Manufacturers of Td
Figure Tdap Picture
Table Major Manufacturers of Tdap
Figure DTaP and Tdap Vaccines Sales Market Share by Applications in 2017
Figure Adult Picture
Figure Pediatric Picture
Figure United States DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Canada DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Germany DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure France DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure UK DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Russia DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Italy DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure China DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Japan DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Korea DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure India DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Pasteur Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Pasteur DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Sanofi Pasteur DTaP and Tdap Vaccines Product
Table Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Pasteur DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Sanofi Pasteur DTaP and Tdap Vaccines Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline DTaP and Tdap Vaccines Product
Table GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global GlaxoSmithKline DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Protein Sciences Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Protein Sciences Corporation DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Protein Sciences Corporation DTaP and Tdap Vaccines Product
Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Protein Sciences Corporation DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Protein Sciences Corporation DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Novartis AG DTaP and Tdap Vaccines Product
Table Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Novartis AG DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Seqirus Headquarter, Established, Main Business and Finance Overview (2017)
Table Seqirus DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Seqirus DTaP and Tdap Vaccines Product
Table Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Seqirus DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Seqirus DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Merck Sharp & Dohme Corp Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Astellas Pharma US, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Product
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Astellas Pharma US, Inc DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Pfizer Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Inc DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Pfizer Inc DTaP and Tdap Vaccines Product
Table Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Inc DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Pfizer Inc DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson DTaP and Tdap Vaccines Product
Table Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Johnson & Johnson DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Lanzhou Institute of Biological Products Co., Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Revenue Market Share in 2017
Table AstraZeneca
Table AstraZeneca DTaP and Tdap Vaccines
Table Emergent BioSolutions Inc
Table Emergent BioSolutions Inc DTaP and Tdap Vaccines
Table Global DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Global DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Global DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Global DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Global DTaP and Tdap Vaccines Price by Manufacturer (2016-2017)
Figure Top 3 DTaP and Tdap Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Top 6 DTaP and Tdap Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Global DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Regions (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Market Share by Regions (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue by Regions (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Regions in 2013
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Regions in 2017
Figure North America DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure North America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure Europe DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure South America DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure South America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure North America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table North America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table North America DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure North America DTaP and Tdap Vaccines Sales Market Share by Countries in 2013
Figure North America DTaP and Tdap Vaccines Sales Market Share by Countries in 2017
Table North America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Countries in 2013
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure United States DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Canada DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Mexico DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table North America DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure North America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure North America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table North America DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table North America DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table North America DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Countries in 2016
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure Germany DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure UK DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure France DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Russia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Italy DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Europe DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Europe DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Europe DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Europe DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Countries 2017
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Countries 2017
Figure China DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Japan DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Korea DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure India DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure South America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table South America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table South America DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure South America DTaP and Tdap Vaccines Sales Market Share by Countries in 2017
Table South America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure Brazil DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Argentina DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Colombia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table South America DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure South America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure South America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table South America DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure South America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure South America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table South America DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table South America DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Countries in 2017
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Countries in 2013
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure UAE DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Egypt DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Nigeria DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure South Africa DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Figure Global DTaP Sales Growth (2013-2018)
Figure Global DTaP Price (2013-2018)
Figure Global Td Sales Growth (2013-2018)
Figure Global Td Price (2013-2018)
Figure Global Tdap Sales Growth (2013-2018)
Figure Global Tdap Price (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Figure Global Adult Sales Growth (2013-2018)
Figure Global Pediatric Sales Growth (2013-2018)
Figure Global DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2018-2023)
Table Global DTaP and Tdap Vaccines Sales Forecast by Regions (2018-2023)
Table Global DTaP and Tdap Vaccines Market Share Forecast by Regions (2018-2023)
Figure North America Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure Europe Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure Asia-Pacific Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure South America Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure Middle East and Africa Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Table Global DTaP and Tdap Vaccines Sales Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Market Share Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Sales Forecast by Application (2018-2023)
Table Global DTaP and Tdap Vaccines Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure DTaP and Tdap Vaccines Picture
Table Product Specifications of DTaP and Tdap Vaccines
Figure Global DTaP and Tdap Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global DTaP and Tdap Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of DTaP and Tdap Vaccines by Types in 2017
Figure DTaP Picture
Table Major Manufacturers of DTaP
Figure Td Picture
Table Major Manufacturers of Td
Figure Tdap Picture
Table Major Manufacturers of Tdap
Figure DTaP and Tdap Vaccines Sales Market Share by Applications in 2017
Figure Adult Picture
Figure Pediatric Picture
Figure United States DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Canada DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Germany DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure France DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure UK DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Russia DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Italy DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure China DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Japan DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Korea DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure India DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria DTaP and Tdap Vaccines Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Pasteur Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Pasteur DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Sanofi Pasteur DTaP and Tdap Vaccines Product
Table Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Pasteur DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Sanofi Pasteur DTaP and Tdap Vaccines Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline DTaP and Tdap Vaccines Product
Table GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global GlaxoSmithKline DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Protein Sciences Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Protein Sciences Corporation DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Protein Sciences Corporation DTaP and Tdap Vaccines Product
Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Protein Sciences Corporation DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Protein Sciences Corporation DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Novartis AG DTaP and Tdap Vaccines Product
Table Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Novartis AG DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Seqirus Headquarter, Established, Main Business and Finance Overview (2017)
Table Seqirus DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Seqirus DTaP and Tdap Vaccines Product
Table Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Seqirus DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Seqirus DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Merck Sharp & Dohme Corp Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Astellas Pharma US, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Product
Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Astellas Pharma US, Inc DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Pfizer Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Inc DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Pfizer Inc DTaP and Tdap Vaccines Product
Table Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Inc DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Pfizer Inc DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson DTaP and Tdap Vaccines Product
Table Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Johnson & Johnson DTaP and Tdap Vaccines Revenue Market Share in 2017
Table Lanzhou Institute of Biological Products Co., Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production Bases, Sales Regions and Major Competitors
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product
Table Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales Market Share in 2017
Figure Global Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Revenue Market Share in 2017
Table AstraZeneca
Table AstraZeneca DTaP and Tdap Vaccines
Table Emergent BioSolutions Inc
Table Emergent BioSolutions Inc DTaP and Tdap Vaccines
Table Global DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Global DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Global DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Global DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Global DTaP and Tdap Vaccines Price by Manufacturer (2016-2017)
Figure Top 3 DTaP and Tdap Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Top 6 DTaP and Tdap Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Global DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Regions (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Market Share by Regions (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue by Regions (2013-2018)
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Regions in 2013
Figure Global DTaP and Tdap Vaccines Revenue Market Share by Regions in 2017
Figure North America DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure North America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure Europe DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure South America DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure South America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Figure North America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table North America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table North America DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure North America DTaP and Tdap Vaccines Sales Market Share by Countries in 2013
Figure North America DTaP and Tdap Vaccines Sales Market Share by Countries in 2017
Table North America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Countries in 2013
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure United States DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Canada DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Mexico DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table North America DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure North America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure North America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table North America DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure North America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table North America DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table North America DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table North America DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table North America DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Countries in 2016
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure Germany DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure UK DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure France DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Russia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Italy DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Europe DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Europe DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Europe DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Europe DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Europe DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table Europe DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Countries 2017
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Countries 2017
Figure China DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Japan DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Korea DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure India DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Southeast Asia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table Asia-Pacific DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure South America DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table South America DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table South America DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure South America DTaP and Tdap Vaccines Sales Market Share by Countries in 2017
Table South America DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure Brazil DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Argentina DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Colombia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table South America DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure South America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure South America DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table South America DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure South America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure South America DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table South America DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table South America DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table South America DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table South America DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Countries (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Countries in 2017
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Countries (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Countries in 2013
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure UAE DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Egypt DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure Nigeria DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Figure South Africa DTaP and Tdap Vaccines Sales and Growth Rate (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Manufacturer (2016-2017)
Figure Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2017
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue by Application (2013-2018)
Table Middle East and Africa DTaP and Tdap Vaccines Revenue Share by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue by Type (2013-2018)
Table Global DTaP and Tdap Vaccines Revenue Share by Type (2013-2018)
Figure Global DTaP Sales Growth (2013-2018)
Figure Global DTaP Price (2013-2018)
Figure Global Td Sales Growth (2013-2018)
Figure Global Td Price (2013-2018)
Figure Global Tdap Sales Growth (2013-2018)
Figure Global Tdap Price (2013-2018)
Table Global DTaP and Tdap Vaccines Sales by Application (2013-2018)
Table Global DTaP and Tdap Vaccines Sales Share by Application (2013-2018)
Figure Global Adult Sales Growth (2013-2018)
Figure Global Pediatric Sales Growth (2013-2018)
Figure Global DTaP and Tdap Vaccines Sales, Revenue and Growth Rate (2018-2023)
Table Global DTaP and Tdap Vaccines Sales Forecast by Regions (2018-2023)
Table Global DTaP and Tdap Vaccines Market Share Forecast by Regions (2018-2023)
Figure North America Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure Europe Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure Asia-Pacific Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure South America Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Figure Middle East and Africa Sales DTaP and Tdap Vaccines Market Forecast (2018-2023)
Table Global DTaP and Tdap Vaccines Sales Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Market Share Forecast by Type (2018-2023)
Table Global DTaP and Tdap Vaccines Sales Forecast by Application (2018-2023)
Table Global DTaP and Tdap Vaccines Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
